Medication info

Posidi Tablet 5 mg (Dapagliflozin Monohydrate Mixture)

Prescription medicationTabletOralExpired
Ingredient · strength
Dapagliflozin Anhydrous Lactose Mixture›7.635mg / 1 tablet
Manufacturer / importer
International Pharmaceuticals Co., Ltd.
Appearance
Yellow, biconvex, round film-coated tablets
Packaging
28 tablets/box [(14 tablets/PTP×2, 7 tablets/PTP×4)]
Approval status
Expired

MFDS item code 202005318 · Approved 2020.07.23

This product's status changed to Expired on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when used in combination with metformin, the recommended starting dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Swallow the tablet whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
International Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control abnormalities
  • cardiovascular diseases
  • cardiovascular risk factors
View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone or in combination therapy while combining with meal planning and exercise. It should be appropriately used under the guidance of a healthcare professional, especially in patients with cardiovascular disease or risk factors who are not sufficiently controlling their blood sugar. This medication helps improve blood sugar management and prevent complications of diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when used in combination with metformin, the recommended starting dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Swallow the tablet whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in certain patients. Patients who are allergic to the active ingredients or excipients of this medication should not take it. This medication should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with inherited conditions that prevent lactose breakdown should not take this medication. It is also not suitable for patients undergoing dialysis. Patients with reduced fluid volume or poor kidney function should use this medication cautiously. This medication can cause blood pressure reduction or changes in kidney function, so these patients should have their fluid status and kidney function carefully evaluated before taking it. During use, symptoms of hypotension or changes in kidney function should be monitored periodically. In patients with moderate to severe reductions in kidney function, blood sugar control effectiveness may decrease, and the decision to administer should be made carefully as needed. This medication contains yellow dye, so patients who are allergic to it should use caution when taking it. This medication can increase the risk of genital infections and urinary tract infections. Especially women and those with a history of infections should be cautious of infection symptoms and receive appropriate treatment if infections occur. If taken with drugs that pose a risk of hypoglycemia, hypoglycemic symptoms may appear, so dosage adjustments may be necessary when combined with insulin or sulfonylureas. Symptoms of dehydration or hypotension due to fluid volume reduction may occur, so particularly elderly patients or those taking diuretics should manage their fluid status closely. This medication can cause serious metabolic abnormalities known as diabetic ketoacidosis, so if symptoms like vomiting, abdominal pain, or difficulty breathing occur, the patient should consult a healthcare provider immediately. It is recommended that pregnant or breastfeeding women do not take this medication, and if pregnancy is confirmed, discontinuation is advised. In the case of overdose, there is no specific antidote, so it is important to receive appropriate treatment based on symptoms. This medication does not significantly affect driving or machinery operation, but caution is needed if there is a risk of hypoglycemia. Always keep out of reach of children and store in the original container to maintain quality.

Side effects

  • Vulvovaginitis
  • Balanitis
  • Genital Infection
  • Urinary Tract Infection
  • Fungal Infection
  • Perineal Gangrene
  • Hypoglycemia
  • Reduced Fluid Volume
  • Thirst
  • Diabetic Ketoacidosis
Show 67 more
  • Dizziness
  • Constipation
  • Dry Mouth
  • Low Back Pain
  • Dysuria
  • Polyuria
  • Nocturia
  • Interstitial Nephritis
  • Vulvar Itching
  • Genital Itching
  • Increased Hematocrit
  • Decreased Renal Creatinine Clearance
  • Dyslipidemia
  • Elevated Serum Creatinine
  • Elevated Blood Urea
  • Weight Loss
  • Rash
  • Angioedema
  • Urosepsis
  • Pyelonephritis
  • Acute Kidney Injury
  • Renal Dysfunction
  • Asthenia
  • Pain
  • Keratitis
  • Chronic Obstructive Pulmonary Disease
  • Hemoptysis
  • Cerebral Hemorrhage
  • Peripheral Arterial Occlusion
  • Angina Pectoris
  • Myocardial Infarction
  • Bile Duct Stones
  • Cholangitis
  • Alcoholic Cirrhosis
  • Depression
  • Suicide Attempt
  • Gastric Adenocarcinoma
  • Anaphylactic Reaction
  • Paresthesia
  • Cerebral Infarction
  • Nerve Compression
  • Urinary Tract Infection
  • Sinusitis
  • Diverticulitis
  • Pelvic Inflammatory Disease
  • Pneumonia
  • Pulmonary Tuberculosis
  • Asthenia
  • Ligament Sprain
  • Urticaria
  • Cold Sweat
  • Itching
  • Arthralgia
  • Musculoskeletal Pain
  • Limb Pain
  • Muscle Weakness
  • Myalgia
  • Osteoarthritis
  • Diabetic Retinopathy
  • Cough
  • Dyspnea
  • Orthostatic Hypotension
  • Palpitations
  • Insomnia
  • Fatty Liver
  • Gallbladder Polyp
  • Tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree Celsius and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow, biconvex, round film-coated tablets

Package unit

28 tablets/box [(14 tablets/PTP×2, 7 tablets/PTP×4)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.